Showing results (111-120 of 264) with videos related to

Sort By:
Pageof 27
Antimicrobial Agents and Chemotherapy|October 29, 2008
Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infectionT Louie, M Miller, C Donskey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2021
Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic TherapyPierre-Jean Maziade, Noam Ship, Jason C Sniffen, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|July 1, 1985
External rhinoplasty approach to transsphenoidal hypophysectomyP J Koltai, J C Goldstein, S M Parnes, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
In vitro activity of ceftazidime-NXL104 against 396 strains of beta-lactamase-producing anaerobesDiane M Citron, Kerin L Tyrrell, Vreni Merriam, et al.
Anaerobe|April 30, 2011
Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methodsKerin L Tyrrell, Yumi A Warren, Diane M Citron, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Ceftaroline versus isolates from animal bite wounds: comparative in vitro activities against 243 isolates, including 156 Pasteurella species isolatesEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2010
In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteriaD M Citron, K L Tyrrell, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2013
In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteriaEllie J C Goldstein, Diane M Citron, Kerin L Tyrrell, et al.
Pageof 27